About My Health Careers Internship MedBlogs Contact us

Futuristic Cancer Therapy - Personalized Medicines

by Ann Samuel on September 26, 2007 at 6:58 PM
Font : A-A+

Futuristic Cancer Therapy - Personalized Medicines

In the peer-reviewed scientific publication Blood, personalized medicine is being highlighted as an extremely promising therapy for cancer patients.

Personalized medicines are customized drugs, tailored to a patient's genes, and those that are designed to work far more efficiently and with reduced side effects. Approved drugs such as the billion dollar anti-breast cancer drug, Herceptin, are a good example of an effective personalized medicine.


The article published in Blood stresses on the need for personalized medicines to treat cancers, which have limited treatment options, such as chronic myeloid leukemia (CML).

CML is cancer of the blood and bone marrow. Here there is an overproduction of undifferentiated white blood cells. Though there are effective treatments for some patients, there is no cure for CML. Leukaemia can develop in anyone, of any age, at any time. CML specifically is most likely to occur over the age of 50. In 2006, approximately 2,869 Australians are projected to have been diagnosed with leukemia; the equivalent of 8 people every day according to the Australian Leukemia Foundation.

The first line of treatment for the majority of CML cancer patients is a drug called Gleevec. Yet, an increasing number of CML patients are developing resistance to Gleevec. As it is becoming less effective in keeping the cancer under control, there is a need for an alternative therapy.

Scientists have new evidence to show that resistance to Gleevec and similar drugs is caused by a particular genetic mutation (T315I mutation) associated with the cause of CML. This mutation is becoming increasingly common in patients. The challenge has been to find a personalized medicine that can fight off cancer caused by a specific genetic mutation.

In the October Blood publication, an accelerated stage CML patient who had developed a resistance to Gleevec therapy as a result of the T315I mutation was successfully treated with Ceflatonin. After ten months of therapy, genetic tests revealed that the patient's level of T315I genetic mutation decreased from 100 per cent to 27 per cent and the patient's health improved.

Ceflatonin is a new personalized therapy for CML patients in development by an Australian-US biotechnology company called ChemGenex Pharmaceuticals. It is currently being tested in patients in clinical trials, which are due for completion next year. Says Dr Greg Collier, the Australian scientist who heads up ChemGenex: "We have strong evidence that Ceflatonin works via different mechanisms to the current therapies and provides a promising alternative for the growing CML patient populations". In a futuristic scenario, doctors would take a saliva swab and place it on a gene chip diagnostic to test for the T315I gene mutation. Immediate DNA test results would determine whether the CML patient tests positive for T315I and is suitable for the Ceflatonin therapy. "This would be personalized medicine at its best," says Dr Collier.

Source: Medindia

News A-Z
News Category
What's New on Medindia
International Day of Persons with Disabilities 2021 - Fighting for Rights in the Post-COVID Era
Effect of Blood Group Type on COVID-19 Risk and Severity
Woman with Rare Spinal Cord Defect from Birth Sues Doctor
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Cancer and Homeopathy Reiki and Pranic Healing Cancer Facts Cancer Common Lifestyle Habits that Cause Diseases Health Benefits of Dandelion Plant Personalized Medicine Immune Checkpoint Inhibitors for Cancer Treatment Non-Communicable Diseases 

Recommended Reading
Genetic Testing Helping Cancer Survivors Fight For Their Loved Ones
Genetic testing identifies whether or not an individual has an increased risk for certain types of ....
Chronic Myeloid Leukemia
Chronic myeloid Leukemia is one of the most common types of blood cancer. It is characterized by .....
Common Lifestyle Habits that Cause Diseases
Cigarette smoking, unhealthy diets, overuse of alcohol, and physical inactivity are some of the most...
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Health Benefits of Dandelion Plant
What is dandelion? Dandelion greens are nutrition powerhouses with a wide range of health benefits. ...
Immune Checkpoint Inhibitors for Cancer Treatment
Immune checkpoint inhibitors are promising drugs to treat a variety of cancers and the FDA has appro...
Non-Communicable Diseases
Non-Communicable Diseases (NCDs) are a group of chronic non-infectious diseases which include Cardio...
Personalized Medicine
Personalized medicine is an advanced method to predict risk of a human to a disease and its early tr...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use